“We are committed to working with industry partners with well-matched development and commercial capabilities”
Partnering is an essential aspect of our business strategy. At PolyMedix we are rapidly advancing a pipeline of innovative drugs for the acute care hospital market. Our drug candidates have been internally discovered and remain unencumbered by licenses.
As our programs proceed through development we intend to enter into strategic alliances to pursue the most efficient development path to bring our products to the market.
Steffen Helmling